A Targeted Approach to Tackling Tumors’ Drug Resistance

Cleveland Clinic radiation oncologist Mohamed Abazeed, MD, PhD, is taking an individualized, targeted approach to study mutations that can affect a tumor’s resistance to chemotherapy. With patient-derived cell lines and mouse xenografts, he produces physiologically relevant test beds for improved gene/drug treatment protocols.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy